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Exome sequencing in a consanguineous Pakistani family identifies a mutational 




Epidermolysis bullosa (EB) is a rare inherited blistering condition of the skin that affects 
approximately 1 in 120,000 people [1]. EB is heterogeneous both clinically and 
genetically. To date, there are more than 30 known clinical variants of EB, with casual 
mutations reported in as many as 18 genes [2]. With a prevalence of 1 in ~350,000 
individuals, dystrophic epidermolysis bullosa (DEB) is one of the major forms of EB [1]. 
DEB may be inherited as a recessive (RDEB, MIM 226600) or dominant (DDEB, MIM 
131750) disease, each further classified into different clinical subtypes [3]. 
All major forms of DEB, whether dominant or recessive, are attributable to mutations 
in the COL7A1 gene, which encodes type VII collagen [4]. This gene is relatively large 
(~32 kb, 118 exons) and, according to the COL7A1 gene variants database, it has 
been found to carry more than 800 individual mutations (http://www.col7a1-
database.info/ Accessed 2018-12-20). While the majority of DEB-associated mutations 
are family-specific, some common mutations have also been identified [5].  
Here, we present a consanguineous Pakistani family with four affected individuals 
suffering from RDEB. The patients were 3 to 12 years old, all born to consanguineous 
and healthy parents (Fig. 1a). The proband is the first child of double first cousins. She 
presented with severe skin fragility and multiple skin injuries at birth, followed by 
mechanically-induced generalized blistering of the skin. Blisters with atrophic scarring 
were, however, more frequent on hands, feet, knees, elbows, and flexural areas (Fig. 
2c and d). Occasionally, the proband experienced chronic wounds at the blistering 
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sites that lasted for more than 6 months. Anonychia, mild dental decay and milia were 
also observed and tissue granulation was restricted to the abdomen. At the time of 
examination (12 years of age), the proband was suffering from anemia and growth 
retardation. Blistering of the oral mucosa was a common feature that caused severe 
swallowing difficulties, especially in her early childhood (Fig. 2a). Progressive 
contractures of hands and feet were noticed. Excessive blistering, contractures, and 
pseudosyndactylism of toes resulted in a ‘mitten-feet’ (Fig. 2d). Generally, more than 
40% of her skin was affected by blisters and associated symptoms. In contrast, the 
proband’s two affected brothers and one first cousin showed less severe symptoms. 
For instance, although generalized blistering of the skin and involvement of the oral 
mucosa was a common feature (Fig. 2b), these patients lacked symptoms like milia, 
atrophic scarring, chronic wounds, anonychia, tissue granulation, growth retardation, 
and pseudosyndactylism of toes. The proportion of affected skin in these patients was 
also significantly lower. Taken together, the clinical presentation of the proband was 
clearly indicative of dystrophic epidermolysis bullosa. We further characterized her 
clinical subtype as “RDEB-generalized intermediate” by using the electronic version of 
a recently developed clinical diagnostic matrix for EB [6]. 
Because of the marked genetic heterogeneity displayed by EB, we performed exome 
sequencing on the proband’s DNA. We first performed homozygosity mapping on the 
sequencing data, which enabled us to identify numerous runs of homozygosity 
(ROHs), globally accounting for 248.57 Mb of the autosomal exome (Fig. 1b). Notably, 
chromosomes 1, 2, and 3 alone contributed to more than 72% of the total homozygosity 
(Fig. 1b). Following a stringent computational analysis of exome data, we retained 37 
high-quality and rare (MAF<1%) homozygous variants that had an impact on the 
protein level (not synonymous nor intronic). Among them, a homozygous missense 
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(NM_000094.3:c.8038G>A:p.Gly2680Ser, genome build hg19) in exon 108 of the 
COL7A1 gene was considered as the potential candidate for the disease etiology. 
Upon Sanger validation, this variant perfectly co-segregated with the phenotype in the 
family (Fig. 1a and c). In silico analysis predicted this Glycine-to-Serine substitution to 
be highly pathogenic. The functional significance of this variant could also be 
recognized by the fact that codon 2680 is highly conserved across vertebrate species, 
both at nucleotide and amino acid levels (Fig. 1d). Finally, c.8038G>A is an extremely 
rare allele (allele frequency = 0.00001992 in gnomAD, absent in South Asians and with 
highest population-specific allele frequency of 0.000123 in Africans) with no 
homozygotes identified [7].  
The clinical outcome and the inheritance pattern of DEB largely depends on the nature 
and position of mutations in the COL7A1 gene, especially when glycine substitutions 
within the triple helix of collagen VII are involved, notably in DDEB. However, a clear 
genotype-phenotype correlation is still missing in the literature [3, 8]. In particular, 
missense variants at codon 2680 of COL7A1 gene have been described in association 
with different clinical subtypes of EB. For example, c.8039G>A:p.Gly2680Asp was 
reported in a proband from the UK to be associated with DDEB, subtype pruriginosa 
[9]. The same amino acid, changed to serine, was detected as a de novo mutation in 
a Polish patient with severe generalized RDEB, in a compound heterozygous state 
with another missense variant (c.425A>G:p.Lys142Arg) [5]. Lastly, this variant was 
reported in conjunction with a novel frameshift mutation 
(c.4871delC:p.Pro1624GlnfsTer86) in a Chinese family with Bart’s Syndrome, a mild 
form of RDEB [10]. This highlights the fact that the absence of genotype-phenotype 
correlation in EB is not uncommon. 
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In summary, we describe here the occurrence of a missense variant 
c.8038G>A:p.Gly2680Ser in the COL7A1 gene, detected homozygously in a 
consanguineous Pakistani family with RDEB. Although this variant was previously 
reported to be associated with EB, to the best of our knowledge, it was never identified 
in a homozygous state. Our findings suggest that this mutation can be pathogenic per 
se, and possibly associated with generalized intermediate RDEB. Furthermore, the 
emergence of this particular glycine substitution in patients from diverse ethnic 
backgrounds such as China, UK, Poland, and Pakistan indicates that this variant most 
likely constitutes a recurrent mutational hotspot in the COL7A1 gene, rather than a 
germline mutation present at low levels in the general population. 
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Figure 1: Molecular diagnosis of patients with RDEB. (a) Pedigree of the family. Filled 
symbols represent affected individuals, whereas open symbols indicate healthy 
subjects. The proband is designated by a black arrow. DFC = Double First Cousin. 
Double lines between symbols indicate consanguineous marriages. (+): wild type 
allele, (-): mutant allele, p.Gly2680Ser. (b) Homozygosity map displaying runs of 
homozygous (ROH) across the genome as vertical peaks. The position of COL7A1 is 
shown on the top of a large 43-Mb ROH on chromosome 3. (c) Sanger sequencing 
results for all available family members. The missense variant 
(c.8038G>A:p.Gly2680Ser) is indicated by a red arrow. While both parents and a 
healthy sister of the proband are heterozygous, all patients are homozygous for this 
mutation. (d) Output from the UCSC genome browser, showing conservation of the 
missense variant c.8038G>A:p.Gly2680Ser (highlighted in red box) across 
vertebrates. 
 
Figure 2:  Clinical presentation of patients with RDEB. (a) Proband showing oral 
blisters, mild teeth decay and facial milia. (b) Proband’s brother showing oral blisters. 
(c) Proband’s hands showing excessive skin eruption as a consequence of frequent 
blisters. (d) Proband’s feet, displaying progressive contractures coupled with 
pseudosyndactylism of toes, resulting in ‘mitten-feet’. 
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